PHASEBIO PHARMACEUTICALS INC (PHAS) Stock Price, Quote, News and Overview

What is the stock price of PHASEBIO PHARMACEUTICALS INC today?

The current stock price of PHAS is 0.0701 USD. The price decreased by -26.21% in the last trading session.

What is the ticker symbol for PHASEBIO PHARMACEUTICALS INC stock?

The exchange symbol of PHASEBIO PHARMACEUTICALS INC is PHAS and it is listed on the Nasdaq exchange.

On which exchange is PHAS stock listed?

PHAS stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for PHASEBIO PHARMACEUTICALS INC stock?

7 analysts have analysed PHAS and the average price target is 1.02 USD. This implies a price increase of 1355.06% is expected in the next year compared to the current price of 0.0701. Check the PHASEBIO PHARMACEUTICALS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is PHASEBIO PHARMACEUTICALS INC worth?

PHASEBIO PHARMACEUTICALS INC (PHAS) has a market capitalization of 3.50M USD. This makes PHAS a Nano Cap stock.

How many employees does PHASEBIO PHARMACEUTICALS INC have?

PHASEBIO PHARMACEUTICALS INC (PHAS) currently has 60 employees.

Is PHASEBIO PHARMACEUTICALS INC (PHAS) expected to grow?

The Revenue of PHASEBIO PHARMACEUTICALS INC (PHAS) is expected to decline by -64.49% in the next year. Check the estimates tab for more information on the PHAS EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy PHASEBIO PHARMACEUTICALS INC (PHAS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of PHAS, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of PHAS, evaluating the profitability, health, valuation and growth aspects
• PHASEBIO PHARMACEUTICALS INC (PHAS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• PHASEBIO PHARMACEUTICALS INC (PHAS) Sales and EPS estimates to see what analysts future expectations are.
• PHASEBIO PHARMACEUTICALS INC (PHAS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• PHASEBIO PHARMACEUTICALS INC (PHAS) Insider and Institutional Ownership to learn about the owners and their transactions.
• PHASEBIO PHARMACEUTICALS INC (PHAS) Stock Chart to make your own analysis
• PHASEBIO PHARMACEUTICALS INC (PHAS) Latest news and press-releases to stay up to date.

Does PHASEBIO PHARMACEUTICALS INC (PHAS) stock pay dividends?

PHAS does not pay a dividend.

When does PHASEBIO PHARMACEUTICALS INC (PHAS) report earnings?

PHASEBIO PHARMACEUTICALS INC (PHAS) will report earnings on 2022-11-22, after the market close.

What is the Price/Earnings (PE) ratio of PHASEBIO PHARMACEUTICALS INC (PHAS)?

PHASEBIO PHARMACEUTICALS INC (PHAS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.13).

ChartMill assigns a fundamental rating of 2 / 10 to PHAS. PHAS may be in some trouble as it scores bad on both profitability and health.

Over the last trailing twelve months PHAS reported a non-GAAP Earnings per Share(EPS) of -2.13. The EPS increased by 36.61% compared to the year before.

ChartMill assigns a Buy % Consensus number of 46% to PHAS. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 59.21% and a revenue growth -64.49% for PHAS